Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-11-22
2023-11-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: Experimental
Within-subjects design with a randomization of the order of tVNS administered parameters
transcutaneous electrical nerve stimulation devices
electrical stimulation through surface electrodes
Group B: Active Comparator
Within-subjects design with a randomization of the order of tVNS administered parameters
transcutaneous electrical nerve stimulation devices
electrical stimulation through surface electrodes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcutaneous electrical nerve stimulation devices
electrical stimulation through surface electrodes
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Major medical illnesses including severe neurological illness (e.g. stroke, seizure history), autoimmune disorders, and severe psychiatric diseases (e.g., schizophrenia)
* Any history of brain surgery, tumor, intracranial metal implantation, pacemakers, or other implanted devices.
* Current (i.e. within 48 hours of the session) prescription medication or over-the-counter medication use.
* Illicit alcohol or drug use. Caffeine (e.g, coffee, energy drinks) consumption prior to the visit.
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Porges, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Florida
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB201903471
Identifier Type: -
Identifier Source: org_study_id